Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A

摘要

Editor,Idiopathic juxtafoveal telangiectasia (IJT) type 2A is characterized by the presence of bilateral acquired ectatic capillaries that involve the temporal half of the fovea (Yannuzzi et al. 2006). Neovascularization and foveal atrophy may occur with progression of the disease and cause severe visual loss (Yannuzzi et al. 2006). We report the successful use of intravitreal ranibizumab and bevacizumab in a case of IJT, complicated by bilateral and simultaneous subretinal neovascularization (SRN).